argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.
Market Cap
$36.02B
P/E Ratio
-170.53
1Y Stock Return
21.29%
1Y Revenue Growth
101.07%
Dividend Yield
0.00%
Price to Book
8.4
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
Yahoo
Evotec appears to have rebuffed Halozyme’s $2.1 billion acquisition attempt. Elsewhere, Argenx has another blockbuster target in sight and an FDA veteran plans retirement.
Yahoo
Phase 2 data establish proof-of-concept of efgartigimod SC in myositis Enrollment to continue in Phase 3 across all three subtypes (IMNM, ASyS, DM) under evaluation in ALKIVIAPotential for efgartigimod SC to be first targeted approach for myositis patients who have limited treatment options November 20, 2024, 7:00 AM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune disease
SeekingAlpha
For Q3 2024, the Fidelity Select Health Care Portfolio fund gained 9.48%, outperforming the MSCI sector index. Click here to read the full commentary.
Yahoo
We recently compiled a list of the 10 Best Immunotherapy Stocks to Buy Now. In this article, we are going to take a look at where argenx SE (NASDAQ:ARGX) stands against the other immunotherapy stocks. The global immunotherapy drugs market is rapidly expanding, with projections to grow from $240 billion in 2023 to $1.3 trillion by […]
SeekingAlpha
For the third quarter, Fidelity Growth Company Fund's Retail Class shares gained 1.34%, lagging the 3.42% advance of the benchmark. Click here to read more.
SeekingAlpha
Artisan Global Discovery Fund portfolio underperformed MSCI AC World SMID Index in Q3 due to negative allocation impact. Read more here.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
STKS | -<0.01% | $101.82M | -29.79% | 0.00% |
HIHO | -0.06% | $8.50M | -1.53% | 6.22% |
BYON | -0.07% | $264.77M | -63.56% | 0.00% |
STLA | -0.07% | $37.05B | -36.20% | 12.91% |
SUP | 0.07% | $70.19M | -7.95% | 0.00% |
CCRN | -0.10% | $341.67M | -50.26% | 0.00% |
NFE | -0.11% | $2.39B | -74.26% | 3.14% |
LFVN | 0.15% | $164.83M | +138.84% | 1.12% |
ACIU | 0.16% | $327.95M | +8.58% | 0.00% |
ATGE | 0.17% | $3.33B | +55.72% | 0.00% |
CRCT | 0.17% | $1.11B | -19.79% | 1.94% |
KR | 0.18% | $42.38B | +33.68% | 2.07% |
GDRX | 0.19% | $1.64B | -26.54% | 0.00% |
NAPA | 0.19% | $1.63B | +6.56% | 0.00% |
CENX | 0.22% | $2.10B | +188.03% | 0.00% |
CCSI | -0.23% | $458.46M | +7.27% | 0.00% |
STVN | 0.25% | $5.35B | -29.32% | 0.29% |
ACIC | 0.26% | $642.09M | +62.64% | 0.00% |
LKQ | 0.27% | $9.85B | -17.18% | 3.13% |
HUM | 0.32% | $35.61B | -42.65% | 1.19% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
IMVT | 36.33% | $3.90B | -18.78% | 0.00% |
IONS | 32.89% | $5.36B | -31.55% | 0.00% |
ALNY | 32.16% | $31.83B | +51.52% | 0.00% |
MNKD | 31.51% | $1.90B | +89.04% | 0.00% |
HALO | 31.22% | $5.81B | +13.94% | 0.00% |
RVMD | 29.99% | $9.55B | +164.83% | 0.00% |
HEI | 29.45% | $38.44B | +59.79% | 0.08% |
UTHR | 27.49% | $16.40B | +59.39% | 0.00% |
HEI.A | 27.30% | $29.86B | +55.28% | 0.10% |
APLS | 27.26% | $3.45B | -41.74% | 0.00% |
ICE | 26.42% | $90.92B | +38.51% | 1.12% |
ARWR | 26.32% | $2.27B | -36.88% | 0.00% |
PGEN | 26.14% | $259.78M | -20.80% | 0.00% |
MU | 25.68% | $113.93B | +33.28% | 0.45% |
CRNX | 25.54% | $5.29B | +85.52% | 0.00% |
KNSA | 25.39% | $1.52B | +33.57% | 0.00% |
AMP | 25.28% | $55.32B | +62.68% | 1.01% |
FDX | 25.14% | $72.11B | +15.09% | 1.77% |
AON | 25.05% | $82.75B | +16.30% | 0.69% |
PH | 24.92% | $90.45B | +62.95% | 0.91% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SCS | -22.64% | $1.49B | +7.86% | 3.05% |
LQDA | -21.34% | $859.06M | +51.04% | 0.00% |
TTC | -16.57% | $8.60B | +0.47% | 1.70% |
TCTM | -15.21% | $7.57M | -41.30% | 0.00% |
SUNS | -14.21% | $103.02M | +31.64% | 1.41% |
PTMN | -13.73% | - | - | 16.24% |
PDD | -10.85% | $144.56B | -11.37% | 0.00% |
AOUT | -10.69% | $122.95M | +13.64% | 0.00% |
ZTO | -10.15% | $11.85B | -10.80% | 4.98% |
MSDL | -9.33% | $1.83B | +0.95% | 7.27% |
CYD | -8.89% | $384.48M | -0.79% | 4.00% |
SRI | -7.88% | $177.48M | -61.01% | 0.00% |
PRPO | -7.66% | $8.89M | -14.59% | 0.00% |
DXYZ | -7.57% | - | - | 0.00% |
NNBR | -7.36% | $197.29M | +68.09% | 0.00% |
BVN | -7.32% | $3.12B | +34.06% | 0.00% |
JBSS | -7.30% | $959.03M | -10.37% | 1.03% |
CRVO | -7.19% | $79.07M | -3.91% | 0.00% |
PULM | -7.13% | $22.32M | +230.27% | 0.00% |
TEM | -7.11% | $8.26B | 0.00% | 0.00% |
Current Value
$602.601 Year Return
Current Value
$602.601 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
FBT | 42.22% | $1.13B | 0.56% |
BBH | 39.38% | $404.59M | 0.35% |
IBB | 38.90% | $6.64B | 0.45% |
XBI | 37.61% | $6.75B | 0.35% |
PTH | 36.09% | $141.72M | 0.6% |
PBE | 33.53% | $253.13M | 0.58% |
VHT | 31.72% | $17.20B | 0.1% |
FHLC | 31.67% | $2.75B | 0.084% |
FXH | 31.00% | $1.16B | 0.62% |
IYH | 30.50% | $3.20B | 0.39% |
IHE | 30.49% | $596.24M | 0.39% |
GNOM | 30.19% | $71.22M | 0.5% |
IXJ | 30.00% | $3.88B | 0.41% |
XLV | 28.96% | $38.54B | 0.09% |
PPH | 28.73% | $606.64M | 0.36% |
DVOL | 28.66% | $55.10M | 0.6% |
PDP | 27.65% | $1.39B | 0.62% |
FTHI | 27.16% | $1.02B | 0.75% |
BUFF | 27.00% | $496.84M | 0.89% |
JMOM | 26.76% | $1.24B | 0.12% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
DBE | 0.03% | $50.92M | 0.77% |
USCI | -0.06% | $185.92M | 1.07% |
GSG | -0.06% | $935.59M | 0.75% |
LGOV | -0.08% | $606.26M | 0.67% |
ICLO | -0.31% | $231.44M | 0.2% |
SOYB | 0.32% | $27.32M | 0.22% |
MUNI | -0.35% | $1.73B | 0.35% |
FMF | -0.40% | $243.44M | 0.95% |
IBTF | 0.41% | $2.07B | 0.07% |
SHY | 0.60% | $22.50B | 0.15% |
VGSH | 0.63% | $19.13B | 0.04% |
CORN | -0.66% | $61.32M | 0.2% |
EMBD | 0.71% | $195.82M | 0.39% |
UCON | 0.73% | $3.20B | 0.85% |
IBTH | 0.76% | $1.08B | 0.07% |
COMT | 0.90% | $842.63M | 0.48% |
IBTJ | 0.95% | $391.30M | 0.07% |
ULST | -1.15% | $535.66M | 0.2% |
DUSB | 1.16% | $812.64M | 0.15% |
STIP | -1.16% | $8.77B | 0.03% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -18.97% | $195.31M | 0.85% |
TAIL | -14.56% | $68.06M | 0.59% |
BTAL | -12.86% | $379.51M | 1.43% |
TPMN | -11.36% | $40.73M | 0.65% |
SHYD | -10.32% | $311.61M | 0.35% |
CLOI | -9.66% | $720.91M | 0.4% |
SEIX | -9.41% | $267.58M | 0.62% |
FLDR | -8.81% | $604.50M | 0.15% |
KRBN | -8.34% | $243.28M | 0.85% |
DFNM | -7.89% | $1.40B | 0.17% |
FLMI | -7.30% | $360.62M | 0.3% |
USDU | -7.26% | $201.83M | 0.5% |
OWNS | -7.22% | $125.21M | 0.3% |
BSCP | -7.10% | $4.04B | 0.1% |
TBIL | -5.62% | $4.39B | 0.15% |
CCOR | -4.94% | $108.59M | 1.18% |
MINT | -4.51% | $11.62B | 0.35% |
KMLM | -4.50% | $348.59M | 0.9% |
WEAT | -4.45% | $123.26M | 0.28% |
UUP | -4.10% | $359.07M | 0.77% |